[article] 
inAutism > 18-6 (August 2014) . - p.631-637

Titre :	Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program
Type de document :	Texte imprimé et/ou numérique
Auteurs :	Jane R. SCHUBART, Auteur ; Fabian CAMACHO, Auteur ; Douglas LESLIE, Auteur
Article en page(s) :	p.631-637
Langues :	Anglais (eng)
Mots-clés :	autism spectrum disorder  children and adolescents  Medicaid  psychotropic medications
Index. décimale :	PER Périodiques
Résumé :	This study characterized psychotropic medication use among Medicaid-enrolled children and adolescents with autism spectrum disorders by examining trends over time, including length of treatment and polypharmacy using 4 years of administrative claims data from 41 state Medicaid programs (2000–2003). The data set included nearly 3 million children and adolescents who were 17 years or younger. Approximately, 65% of children with autism spectrum disorder received a psychotropic medication. The results indicate an increasing overall trend in the use of psychotropic drugs among children and adolescents with autism spectrum disorders. Among the different classes of psychotropic drugs, antipsychotics were the most common. Increasing trends in polypharmacy were observed both within and between medication classes.
En ligne :	http://dx.doi.org/10.1177/1362361313497537
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=237

[article] Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program [Texte imprimé et/ou numérique] / Jane R. SCHUBART, Auteur ; Fabian CAMACHO, Auteur ; Douglas LESLIE, Auteur . - p.631-637.
Langues : Anglais (eng)
in Autism > 18-6 (August 2014) . - p.631-637

Mots-clés :	autism spectrum disorder  children and adolescents  Medicaid  psychotropic medications
Index. décimale :	PER Périodiques
Résumé :	This study characterized psychotropic medication use among Medicaid-enrolled children and adolescents with autism spectrum disorders by examining trends over time, including length of treatment and polypharmacy using 4 years of administrative claims data from 41 state Medicaid programs (2000–2003). The data set included nearly 3 million children and adolescents who were 17 years or younger. Approximately, 65% of children with autism spectrum disorder received a psychotropic medication. The results indicate an increasing overall trend in the use of psychotropic drugs among children and adolescents with autism spectrum disorders. Among the different classes of psychotropic drugs, antipsychotics were the most common. Increasing trends in polypharmacy were observed both within and between medication classes.
En ligne :	http://dx.doi.org/10.1177/1362361313497537
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=237